Twin Tree Management, LP Blueprint Medicines Corp Transaction History
Twin Tree Management, LP
- $50 Billion
- Q3 2024
A detailed history of Twin Tree Management, LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Twin Tree Management, LP holds 336,400 shares of BPMC stock, worth $38.4 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
336,400
Previous 169,600
98.35%
Holding current value
$38.4 Million
Previous $18.3 Million
70.16%
% of portfolio
0.06%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding BPMC
# of Institutions
355Shares Held
60.7MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$762 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$758 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$614 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$452 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$315 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.81B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...